Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Intra-dialytic Hypertension
NCT07231900Phase 3Not yet recruiting
- Sponsor
- Shamir Medical Center
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) and metabolic acidosis comparing Sodium bicarbonate with Placebo (2 arms). Primary endpoint: Blood pressure at 1 month. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
hypertension (HTN)metabolic acidosis
Beyond the preview
Go deeper on NCT07231900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231900.